Document ID: chunk:federal_register_of_legislation:C2015A00089:clause:2_1
Version: federal_register_of_legislation:C2015A00089
Segment Type: clause
Provision Reference: sch 2 cl 1
Character Range: 19039–19919

1  After subsection 85(6)
Insert:

Schedule equivalents
 (6A) If the Minister determines a brand of a pharmaceutical item under subsection (6), the Minister may, by legislative instrument, determine that, for the purposes of paragraph 103(2A)(b), the brand is to be treated as equivalent to one or more other brands of pharmaceutical items.
 (6B) In deciding whether the brand of pharmaceutical item is to be treated as equivalent to one or more other brands of pharmaceutical items, the Minister must have regard to any advice given by the Pharmaceutical Benefits Advisory Committee.
 (6C) If, on 1 November 2015, the Schedule of Pharmaceutical Benefits specifies that a brand of a pharmaceutical item is equivalent to one or more other brands of pharmaceutical items, the specification is taken to have been made following a determination to that effect under subsection (6A).